Juan C. Jaen, President at Arcus Biosciences, Inc. (RCUS), sold 192,918 shares at $20.19 ($4.0M) on 2025-10-28, disclosed to the SEC on 2025-10-30.
Scheduled sale ($4.0M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.19 | 19,019 | $384K | 9.6% |
| 2 | $20.19 | 19,019 | $384K | 9.6% |
| 3 | $20.49 | 47,675 | $977K | 24.4% |
| 4 | $20.49 | 47,675 | $977K | 24.4% |
| 5 | $21.53 | 29,365 | $632K | 15.8% |
| 6 | $21.53 | 29,365 |
| $632K |
| 15.8% |
| 7 | $22.04 | 800 | $18K | 0.4% |
| Total | $20.75 avg | 192,918 | $4.0M | 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |